Named Patient Medicines

  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·          fast weight gain (greater than 10 pounds within a week) ·          bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m

  In a clinical trial, half of patients with metastatic colon or rectal cancer treated with LONSURF® (trifluridine and tipiracil) Tablets were still alive at 7.1 months and half of patients who received placebo were still alive at 5.3 months were alive. Worsening of disease or death occurred in 88% of patients treated with LONSURF and 94% of patients receiving placebo. In the clinical trial, half of the patients with metastatic colon cancer treated with LONSURF were still alive at 5.7 months and half of the patients who received placebo were still alive at 3.6 months. Worsening of disease or death occurred in 85% of patients treated with LONSURF and 92% of patients receiving placebo.   Signs and Important Safety Information LONSURF is a prescription medicine used to treat adults • Colorectal cancer that has spread to other parts of the body and has been previously treated or cannot receive certain chemotherapy drugs. • A type of stomach cancer called gastric cancer, including c

 Type 2 diabetes is a disease in which your body does not produce enough of a hormone called insulin or does not use insulin as it should. So when there is a problem with insulin, glucose builds up in your blood. You probably have this called high blood sugar. The other two main types are gestationalgia, in which your body stops making insulin, and gestationalgia, which occurs in pregnant women. You may not even know you have type 2 diabetes until it affects your health. About 1 in 4 people with the condition do not know they have the disease. Symptoms of Type 2 Diabetes • Excessive thirst. When sugar builds up in your blood, your kidneys work longer to get rid of it. This draws fluid out of your tissues and makes you dehydrated, making you feel thirsty. • More hunger. Since diabetes can block glucose from getting into your cells, you still feel hungry after eating. • Frequent urination. You will urinate more because your kidneys are working to get rid of the extra sugar in your

What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy

What is Bydureon (exenatide)? Bydureon is a brand-name medicine used to improve blood sugar levels in people with type 2 diabetes. It comes as a liquid suspension to be given by injection under the skin (subcutaneously). Bydureon contains a medicine called extended-release exenatide. Bydureon vs Bydureon BCise Bydureon BCise is another form of Bydureon. It contains the same medicine (extended-release exenatide). Bydureon and Bydureon BCise work in the same way and have very similar effects in the body. You push the autoinjector against your skin, and it injects the medicine automatically. There are fewer steps required to inject Bydureon using this autoinjector than using a syringe or pen injector. This can make Bydureon BCise easier to use than Bydureon. In clinical studies, Bydureon reduced hemoglobin A1c (HbA1c) by approximately 0.88 to 1.6 percent after 24 to 28 weeks of treatment. In the Bydureon BCise study, HbA1c was reduced by approximately 1.07 to 1.39 percent after

CELSENTRI is an antiretroviral drug used in the treatment of human immunodeficiency virus type-1 (HIV-1) infection. Its active ingredient, Maraviroc, belongs to a group of drugs called CCR5 antagonists. CELSENTRI blocks the entry of HIV-1 into cells in your blood that are attacked by HIV (called CD4 or T-cells). CELSENTRI works by blocking a receptor called CCR5 that HIV uses to gain entry into these cells. CellSentry reduces the amount of HIV in your body and boosts your immune system. HOW TO BUY CELSENTRI Maraviroc 300mg Tablets? CELSENTRI Maraviroc 300mg CELSENTRI (Maraviroc) Tablets 300mg Suppliers in India. Elevier India New Delhi, India. Alleviare Life Sciences Pvt. Ltd. is a Consulting Pharmaceutical company specialized in providing medicines under Enrolled Patient Program/Manage Access Programmes. The Enrolled Patient Program / Management Access Program is designed by the Government of India and the governments of several countries around the world for patients who have